Ocular Therapeutix, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2025 | 31.79 M | $371.57 M | 62.10% | 18.42% |
| VR ADVISER, LLC | 11/14/2025 | 13.16 M | $153.86 M | 3.13% | 7.63% |
| SUMMER ROAD LLC | 11/07/2025 | 12.58 M | $147.05 M | -9.42% | 7.29% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 11.93 M | $139.49 M | -16.53% | 6.91% |
| BLACKROCK, INC. | 11/12/2025 | 10.56 M | $123.41 M | 0.10% | 6.12% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 10.25 M | $119.82 M | 38.51% | 5.94% |
| VANGUARD GROUP INC | 11/07/2025 | 9.16 M | $107.12 M | 9.19% | 5.31% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 6.12 M | $71.51 M | 15.00% | 3.54% |
| CITADEL ADVISORS LLC | 11/14/2025 | 5.70 M | $66.68 M | 16.74% | 3.30% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 4.60 M | $53.79 M | 141.64% | 2.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 4.00 M | $46.81 M | 2.93% | 2.32% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 3.86 M | $45.07 M | 3,136.12% | 2.23% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 3.50 M | $40.88 M | 2.25% | 2.03% |
| STATE STREET CORP | 11/14/2025 | 3.46 M | $40.45 M | -1.40% | 2.00% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 3.42 M | $40.03 M | 2,003.21% | 1.98% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 3.34 M | $39.03 M | 1.65% | 1.93% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 3.25 M | $37.99 M | 47.73% | 1.88% |
| DELTEC ASSET MANAGEMENT LLC | 10/24/2025 | 2.76 M | $32.29 M | -1.16% | 1.60% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 2.62 M | $30.67 M | 8.21% | 1.52% |
| MORGAN STANLEY | 11/14/2025 | 2.47 M | $28.82 M | -4.12% | 1.43% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 2.19 M | $25.59 M | 902.91% | 1.27% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 2.05 M | $23.96 M | 3,728.97% | 1.19% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.67 M | $19.48 M | 121.86% | 0.97% |
| MARSHALL WACE, LLP | 11/13/2025 | 1.60 M | $18.72 M | 100.00% | 0.93% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 1.60 M | $18.65 M | 0.00% | 0.92% |
| UBS GROUP AG | 11/13/2025 | 1.25 M | $14.59 M | -36.48% | 0.72% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.18 M | $13.74 M | 1.65% | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2025 | 1.17 M | $13.62 M | 14.81% | 0.68% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.15 M | $13.46 M | 58.07% | 0.67% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.12 M | $13.14 M | 2.62% | 0.65% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2025 | 1.08 M | $12.58 M | 0.98% | 0.62% |
| INVESCO LTD. | 11/13/2025 | 1.04 M | $12.20 M | -32.16% | 0.60% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 1.01 M | $11.83 M | 14.43% | 0.59% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 795.97 K | $9.30 M | 31.53% | 0.46% |
| PATIENT SQUARE CAPITAL LP | 11/10/2025 | 715.00 K | $8.36 M | -12.56% | 0.41% |
| CETERA INVESTMENT ADVISERS | 11/14/2025 | 714.07 K | $8.35 M | 1.23% | 0.41% |
| CITIGROUP INC | 11/10/2025 | 673.35 K | $7.87 M | 574.40% | 0.39% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 638.95 K | $7.47 M | -64.28% | 0.37% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 10/23/2025 | 617.52 K | $7.22 M | -28.36% | 0.36% |
| KNOLL CAPITAL MANAGEMENT, LLC | 11/14/2025 | 600.40 K | $7.02 M | 0.00% | 0.35% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 598.00 K | $6.99 M | 100.00% | 0.35% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 555.15 K | $6.49 M | 138.38% | 0.32% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 540.70 K | $6.32 M | 443.42% | 0.31% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 518.75 K | $6.06 M | 100.00% | 0.30% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 466.18 K | $5.45 M | 100.00% | 0.27% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 447.12 K | $5.23 M | -41.11% | 0.26% |
| AXA INVESTMENT MANAGERS S.A. | 11/14/2025 | 439.88 K | $5.14 M | 100.00% | 0.25% |
| BARCLAYS PLC | 11/12/2025 | 411.62 K | $4.81 M | -17.02% | 0.24% |
| APTUS CAPITAL ADVISORS, LLC | 11/12/2025 | 402.47 K | $4.70 M | 4.41% | 0.23% |
| SECOND LINE CAPITAL, LLC | 11/19/2025 | 402.47 K | $4.70 M | 4.41% | 0.23% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ocular Therapeutix, Inc. institutional Ownership - FAQ's
During the previous two years, 264 institutional investors and hedge funds held shares of Ocular Therapeutix, Inc.. The most heavily invested institutionals were:
FMR LLC: 31.79 M
VR Adviser, LLC: 13.16 M
SUMMER ROAD LLC: 12.58 M
Deep Track Capital, LP: 11.93 M
BlackRock, Inc.: 10.56 M
Avoro Capital Advisors LLC: 10.25 M
109.03% of Ocular Therapeutix, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 202.73 M shares in the last 24 months. This purchase volume represents approximately $2.52 B in transactions.